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Abstract
This study investigated the association between functional status in fibromyalgia patients and
helplessness, self-efficacy, social support and cognitive appraisal. Patients' assessments of their
pain and global severity of illness (as rated on a visual analog scale) as well as a physician's
rating of global severity, tended to correlate with helplessness and pain-related self-statements.
Patients' perceived change in difficulty and satisfaction regarding activities of daily living
(measured by means of the Modified Health Assessment Questionnaire) correlated negatively
with self-efficacy beliefs and relationship strain, while patients' subjective assessment of their
global improvement was related to self-efficacy. The objective rating by a physician of tender
points correlated with catastrophizing self-statements and opportunity for confiding.
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Opsomming
In hierdie studie is die verband tussen die funksionele status van pasiënte met fibromialgie en die
belewing van hulpeloosheid, selfdoeltreffendheid, sosiale ondersteuning en bepaalde kognisies
ondersoek. Pasiënte se beoordeling van hulle ervaring van pyn en die globale ems van hulle
siekte (soos beoordeel met behulp van 'n visuele analoogskaal), asook die geneesheer se
beoordeling van die ems van hulle siekte, het met hulpeloosheid en pynverwante kognisies
gekorreleer. Hulle waarneming van die verandering in die uitvoerbaarheid van, en hulle
tevredenheid met hulle daaglikse aktiwiteite (gemeet met die Modified Health Assessment
Questionnaire) het negatief verband gehou met selfdoeltreffendheid en verhoudingstremmings,
terwyl hulle globale beoordeling van die verbetering in hulle siekte met selfdoeltreffendheid
gekorreleer het. Die objektiewe assessering deur 'n geneesheer van sensitiewe liggaamsareas het
verband getoon met disfunksionele kognisies (katastrofering) en vertroue in ander.
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11. LITERATURE REVIEW
1.1 Fibromyalgia Syndrome
Fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain disorder, often classified as a
non-articular rheumatologic condition (Turk & Ellis, 2003). The cardinal features of FMS are
widespread pain and hypersensitivity to palpitation at specific body locations or tender points in
the upper and lower body (Wolfe, et al., 1990). The classification criteria for FMS are based on
the American College of Rheumatology multicenter study published in 1990 (Wolfe, et al.,
1990). The results of this study suggested two primary distinguishing factors that are specific for
FMS: (a) a history of widespread pain of at least 3 months' duration, and (b) report of pain or
palpitation in at least 11 of 18 tender point sites throughout the body, especially the back, neck,
shoulders, throat, and thighs.
The etiology of FMS remains unclear and speculation regarding the underlying causal
mechanisms, and whether these mechanisms are physical or psychological in nature, persists
(Turk & Ellis, 2003; Winfield, 1999). According to Nezu, Nezu and Lombardo (2001) FMS can
occur reactively (in response to trauma of systemic infection) or insidiously (no known
precipitating event). There is also considerable controversy about the extent to which FMS may
overlap with psychiatric diagnoses of somatization and depression (Johnson, DeLuca, &
Natelson, 1999; Winfield, 1999). At present, FMS is conceptualized in the same way as other
chronic disorders, as having both physical and emotional components that affect the quality of
life of sufferers (Burckhardt, Clark, & Bennett, 1993).
Patients with FMS typically report functional limitations and psychological dysfunction,
including chronic fatigue (78.2%), altered sleep physiology (75.6%), feelings of stiffness
(76.2%), headaches (54.3%), irritable bowel disorders (35.7%), and depression and anxiety
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2(44.9%) (Wolfe, et aI., 1990). In an ongoing study of 97 fibromyalgia patients, Turk and Ellis
(2003) asked participants which factors were associated with improvement and exacerbation of
their symptoms. Fifty-nine to 67% reported increases in physical activity, stress and poor sleep
as aggrevating factors, whereas resting and relaxing were associated with improvement of
symptoms in 51% to 62% of patients.
1.2 Prevalence and Treatment of FMS
Fibromyalgia is one of the most common disorders encountered in outpatient rheumatologic
clinics (White, Speechley, Harth, & 0stbye, 1995). The true prevalence of fibromyalgia is
unknown, but it is estimated to affect between 0.66% and 10.50% of the population, with the
female-to-male ratio of patients seeking treatment approximately 8 to 1 (Schochat, Croft, &
Raspe, 1994; Wolfe, 1993). The natural course seems to be chronic and nonprogressive, with
fluctuations in symptom severity. Radiographic and laboratory findings tend to be negative
(Turk & Ellis, 2003), but several studies have found abnormal brain metabolism of substances
such as serotonin, melatonin and growth hormone in fibromyalgia (Dauvilliers & Touchon,
2003). Recent research by Kaplan, Schmidt and Cronan (2000) reported that FMS has a greater
impact on a individual's health status than cancer, osteoarthritis, AIDS, and macular
degeneration. A well-known fact and a source of great frustration for clinicians as well as
patients are that optimal management of FMS is challenging and with discouraging results. No
changes pathognomonical or any known cure for FMS have been found, and comprehensive
evidence-based guidelines for treatment have not been reported. The diversity of therapeutic
programs and the low efficacy of current therapies reflect this lack of knowledge (Goldenberg,
1993). Tricyclic antidepressants, nonsteroidal anti-inflammatory drugs and muscle relaxants
have been the primary focus of clinical trials (Carette, et al., 1994; Goldenberg, Felson, &
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3Dinerman, 1986; Santadrea, Montrone, Sarzi-Puttni, Boccassini, & Caruso, 1993; Scudds,
McCain, Rollman, & Harth, 1989), but the results of these studies are difficult to integrate
because of the differences in variables, outcome criteria, and measuring instruments used (White
& Harth, 1996). Most of the nonpharmological treatment studies are unimodal, incorporating
physical fitness training, patient education, EMG-biofeedback, cognitive-behaviour therapy,
relaxation training and meditation-based stress reduction programs (Buckelew, et aI., 1998;
Burckhardt, Mannerkorpi, Hedenberg, & Bjelle, 1994; Carette, et al., 1994; Horven Wigers,
Stiles, & Vogel, 1996; Keel, Bodoky, Gerhard, & Muller, 1998; Lynch, 2004; Nicassio,
Radojevic, et aI., 1997; Sarnoch, Adler, & Scholz, 1997). These treatments appear to have some
short-term benefits, but the initial positive results are often not maintained (Horven Wigers, et aI.,
1996).
The literature reveals major limitations regarding treatment outcome studies, e.g., many treatment
trials are compromised by short duration and lack of masking. There are at present no medical
therapies that have been specifically approved by the US Food and Drug Administration for the
management of FMS, and a number of other commonly used FMS therapies, such as trigger point
injections, have not been adequately researched (Goldenberg, Burckhardt, & Crofford, 2004).
Although there is currently no accepted cure for FMS, some pharmacological and
nonpharmacological interventions showed clinical benefit. As FMS is a multifactorial syndrome,
it is likely that the best treatment options will encompass multiple interventions. Based on
current evidence, a multidisciplinary stepwise program emphasizing education, certain
medications, exercise, cognitive psychotherapy, or a combination of these four interventions,
should be recommended as the treatment of choice (Goldenberg, Burckhardt, & Crofford, 2004) .
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41.3 Association between Fibromyalgia and Psychological Variables
Numerous studies have investigated the relationship between psychological variables and FMS
and other rheumatic diseases. Patients with FMS report a substantially compromised quality of
life compared to patients with other rheumatologic and chronic diseases (Burckhardt, et al.,
1993). FM pain has been associated with higher levels of depression, greater use of avoidant
pain coping strategies, lower quality-of-well-being, and more frequent hospitalizations
(Schoenfeld-Smith, Nicassio, Radojevic, & Patterson, 1995). In addition, these patients report
significantly more distress, especially life stress or chronic daily hassles, than do patients with
rheumatoid arthritis or healthy control subjects (Dailey, et al., 1990; Uvegas, et al., 1990).
Several previous studies suggested that psychological distress is central to the pain experience
and overall morbidity of fibromyalgia (Winfield, 1999).
From a biopsychosocial or behavioural approach, pain disability is determined not only by
underlying pathology, but also by emotional, cognitive and environmental factors (Bradley,
1989). As Winfield (1999) appropriately stated in his article on pain in FMS: "Nowhere in
medicine is Engel's biopsychosocial model of chronic illness more appropriate than in
fibromyalgia." (p. 55) It is widely recognized that different psychological variables and patients'
social circumstances influence the success of treatment, especially in a chronic, multidimensional
illness like FMS. However, the relationship between psychological variables and treatment
outcome for FMS is poorly understood. Although most studies include some self-report
instruments to measure pain severity, other variables such as functional status (e.g., perceived
disability) and psychological distress are frequently not included (Turk, Okifuji, Sinclair, &
Starz, 1998). A review of the research literature reveals that four psychological variables are
frequently associated with FMS: self-efficacy, perceived social support, helplessness and pain-
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5related cognitions (Buckelew, et al., 1998; Franks, Cronan, & Oliver, 2004; Hallberg & Carlsson,
1998; Nicassio, Radojevic, et al., 1997; Nicassio, Schuman, Radojevic, & Weisman, 1999;
Prince, Bernard, & Edsall, 2000; Rudnicki, 2001). These variables and their association with
FMS will be discussed next.
a) Helplessness refers to a psychological state in which individuals expect that their efforts will
be unsuccessful (DeVellis & Callahan, 1993). According to studies of helplessness theory
(Peterson, 1982), the state of helplessness in chronic illness may be characterized by (a)
motivational deficits (e.g., lack of effort to cope with symptoms), (b) cognitive deficits (e.g.,
beliefs that a coping response will not reduce the pain), and (c) affective deficits (e.g., increased
anxiety and/or depression). Research suggests that helplessness beliefs playa role in augmenting
the impact of pain and disability in FMS (Ahles, Khan, Yunus, Spiegel, & Masi, 1991; Nicassio,
et al., 1999; Schoenfeld-Smith, et al., 1995). The largely unpredictable nature of FMS symptoms
and the absence of scientific knowledge regarding the etiology and treatment of FMS, may
contribute to considerable subjective uncertainty, feelings of personal helplessness, passive
resignation and other forms of dysfunctional coping behaviour in many patients (Nicassio, et al.,
1997). The helplessness construct may be especially important in explaining the high levels of
depression and functional impairment that are associated with FMS (Ahles, et al., 1991;
Schoenfeld-Smith, et al., 1995).
A study by Nicassio et al. (1999) showed helplessness scores to be significantly higher for FMS
patients (M = 17.93) than scores reported by Tayer, Nicassio, Radojevic and Krall (1996) for
systemic lupus erythematosus (SLE) patients CM = 14.45) with the Rheumatology Attitudes
Index (RAl), and by Stein, Wallston, Nicassio and Castner (1988) for rheumatoid arthritis (RA)
patients (M = 15.03) with the Helplessness Subscale of the Arthritis Helplessness Index (AHI).
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6Nicassio et al. (1997) conducted a treatment outcome study, consisting of education about the
nature of FMS, training in progressive relaxation, behavioural goal-setting, and activity pacing to
increase functioning. They found significantly lower pain scores in the high helplessness change
group at follow-up, compared to the low helplessness change group. There was also a gradual
trend in improvement of depression across post-treatment and follow-up for the high helplessness
change group, but no improvement for the low helplessness change group. They also found that
an improvement in helplessness was associated with a decrease in passive coping strategies in
FMS patients. These results suggest that the provision of information and an increased sense of
mastery may have contributed to a decrease in helplessness and dysfunctional coping.
b) Self-efficacy (SE) refers to beliefs that one can competently cope with a challenging situation
or task, and that one has the ability to affect behaviour (Bandura, 1977). For example, it was
found that individuals with higher perceived self-efficacy tend to persist with active coping
behaviours until successful (Buckelew, et aI., 1998). Although self-efficacy is related to other
psychological concepts such as locus of control, learned helplessness, and self-esteem, it differs
in that it is behaviour-specific. Thus, self-efficacy is measured as a specific state, not a
generalised trait (Lorig, Chastam, Ung, Shoor, & Holman, 1989). Self-efficacy is considered an
important predictor of pain and disease severity measures in the fibromyalgia population
(Buckelew, et aI., 1998). For example, higher baseline levels of self-efficacy are associated with
less self-reported baseline pain (Buckelew, Murray, Hewett, Johnson, & Huyser, 1995), fewer
pain behaviours (Buckelew, et aI., 1994), and less impairment on physical activity measures
(Buckelew, et aI., 1995). Self-efficacy for dealing with FMS pain, as well as with symptoms
other than impaired physical functioning, were identified as significant predictors of treatment
and/or research protocol adherence in a meditation-based stress reduction treatment intervention
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7for female fibromyalgia patients (Lynch, 2004). A study by Franks et al. (2004) found larger
social support networks for FMS patients to be predictive of greater levels of self-efficacy for
dealing with pain. Both the size of the network and satisfaction with social support predicted
greater levels of self-efficacy for coping with symptoms. Thus, both the number and the quality
of social relationships were important determinants of the belief that the symptoms of FMS can
be managed successfully. Higher levels of informational support or feedback predicted lower
levels of self-efficacy for functioning with FMS. Individuals who do not believe that they are
able to deal with the limitations in function associated with FMS may seek and receive
information to help them cope with living with FMS. However, these findings could also
indicate that individuals who receive too much instrumental support from friends and family feel
as if they are unable to function on their own. A directional relationship could not be established
with this cross-sectional design (Franks, et al., 2004).
c) Social support refers to specific supportive behaviours on the part of others or to the
perceived availability of different forms of support (Goodenow, Reisine, & Grady, 1990). In
times of trouble or stress an individual relies on the perception of qualitative support, believing
that others are available to help him or her to cope with the particular demands posed by the
environment.
Given the demanding and stressful nature of a chronic disabling disease, it could be expected that
adjustment and functioning would show a strong relationship to perceived qualitative support
(Goodenow, et aL, 1990). The demands of family and work and the need for social support exert
a serious and significant effect on every dimension of health status in patients suffering from
FMS (Reisine, Fifield, Walsh, & Feinn, 2003). The past three decades have seen a rapid growth
in research in the area of social support, emphasizing the importance of social support to the
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8maintenance of health (Lackner, 2000). Recent research has suggested that how, when and why
people activate their support networks may differ when long-term chronic stress is involved.
Lackner (2000) examined the effects of a chronic illness on the processes of social support.
Through 60 qualitative interviews with people who were experiencing multiple sclerosis or
fibromyalgia, supportive transactions between participants and their social support networks were
explored. It was found that participants were actively engaged in their own social support. They
defined what they want in a supportive person and actively seeked the type of support that most
closely fit their definition. They facilitated support but also constrained people's ability to
provide it to them by actively engaging in how that support should be provided.
A cross-sectional study, examining the relationship between social support, coping, and
subjective well-being, presented a plausible causal sequence: coping influences subjective well-
being via social support. This is only true, however, for coping by awaiting/avoidance. Coping
by awaiting/avoidance led to less social support and this decrease in social support influenced
subjective well-being negatively (Savelkoul, Post, De Witte, & Van Den Borne, 2000).
In a study by Franks et al. (2004) ofFMS patients, larger social support networks were associated
with greater levels of self-efficacy for pain and symptom management, while the perceived
quality of social support was associated with lower levels of depression, helplessness, mood
disturbance, impact of FMS, higher levels of self-efficacy for function and symptom
management, as well as with overall psychological well-being. These findings indicate that the
quality rather than the available quantity of social support is important in determining effective
funtional and psychological outcomes in women with FMS. Nicassio, Schuman, Kim, Cordova
and Weisman (1997) examined specific psychosocial factors associated with complementary
treatment use (exercise, bed rest, vitamins, heat treatment, and spirituality/praying) in
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9fibromyalgia. They found that quality of social support and pain coping strategies did not predict
the use of these complementary treatments.
d) Cognitive self-statements regarding environmental events are guided by underlying cognitive
schemata. It is well recognized that these cognitive appraisals may play an important role in the
perception of pain and the response to treatment interventions (Flor, Behle, & Birbaumer, 1993).
Cognitive-behavioural theories suggest that a sense of uncontrollability of one's pain and
disability leads to negative mood and maladaptive behaviours (e.g., avoidance), which perpetuate
functional limitations as well as emotional and physical distress (Bradley, 1989). A number of
studies have demonstrated that cognitive appraisal is indeed related to the degree of disability and
the response to treatment in chronic pain patients (e.g. Biedermann, McGhie, Monga, & Shaks,
1987; Brown & Nicassio, 1987; Newton & Barbaree, 1987; Phillips, 1987). Thieme, Turk and
Flor (2004) investigated pain-related cognitive self-statements in patients with fibromyalgia in
their study of the comorbidity of depression and anxiety in FMS. Their results suggested that
FMS is not a homogeneous condition, but shows varying proportions of comorbid anxiety and
depression dependent on the psychosocial characteristics (e.g. coping behaviour) of the patients .
.
No other studies of cognitive appraisal and fibromyalgia were found in the literature. However,
Flor et al. (1993) concluded that an individual's appraisals of pain as well as his/her ability to
cope with it are central in determining how disabled a person becomes or remains.
2. OBJECTIVE
A review of the literature revealed that there is currently no clarity on the etiology of FMS. Several
researchers consider psychological variables to be associated with the onset and course of FMS.
However, there is a need for further research into the relationship between FMS and psychological
factors. Consequently, the present study investigates the association between functional status in
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FMS patients and particular psychological variables (helplessness, self-efficacy, social support and
cognitive appraisal).
3. METHODOLOGY
3.1 Participants
Participants were. recruited from patients of a general medicine practice in Potchefstroom, South
Africa, all previously diagnosed with FMS. The diagnosis of FMS was made by the same physician
for all patients, using the American College of Rheumatology's criteria (Wolfe, et al., 1990). Since
the diagnosis was made, these patients received medication (mainly low doses of tricyclic
antidepressants, non-steroidals, and/or analgesics), trigger point injections, and education on FMS,
given by individual appointment at regular visits to the physician.
These patients were contacted and invited to participate in the study. Forty-three patients responded
and then completed the measuring instruments individually, followed by a medical examination.
Patients were excluded if they had been diagnosed with any concommitant rheumatologic conditions
such as RA, SLE, Hashimoto's disease, Sjogren's syndrome, or scleroderma, or other serious
conditions such as cardiovascular diasease, central nervous system disorders, or psychiatric disorders
such as psychosis or bipolar mood disorder. Cases of substance abuse or involvement in litigation
for disability income were also excluded.
This process resulted in a sample of 31 patients, all female, with a mean age of 44.03 years (SD =
12.45). The average duration of FMS since its diagnosis was 4.90 years. To control their FM
symptoms, 71.0% of the participants reported use of analgesics, 41.9% reported use of non-
steroidals, and 54.8% reported use of low dose tricyclic antidepressants.
3.2 Measuring Instruments
3.2.1 Functional Status
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In attempting to identify FMS patients who respond to treatment, some researchers have used their
own definitions or criteria of clinically significant improvement, e.g., clinical judgement (Jaeschke,
Adachi, Guyatt, Keller, & Wong, 1991), the patient's rating of treatment efficacy on improvement
(Simms, Felson, & Goldenberg, 1991), or a 50% improvement in various FM symptoms (Carette, et
aI., 1994). The validity of these criteria has not been tested. A review of the literature revealed that
different criteria for determining functional status in FMS are curretly in use and that there are not a
single set of criteria or procedures which are generally accepted.
In the present study functional status was determined by means of the following scales.
3.2.1.1 Modified Health Assessment Questionnaire (MHAQ)
The MHAQ (Pincus, et aI., 1983), an abbreviated version of the Health Assessment Questionnaire
(HAQ), is a self-report health status measuring instrument which gives an indication of a patient's
satisfaction regarding activities of daily living (ADL) and perceived change in difficulty. The
MHAQ has been shown to have comparable reliability and validity to the lengthier HAQ (Fries,
Spitz, Kraines, & Holman, 1980), and has been used in numerous fibromyalgia studies (e.g., Reisine,
et aI., 2003; Wolfe, et aI., 1997). The questionnaire includes 8 activities of daily living to which
patients have to rate their performance according to degree of (a) difficulty, (b) satisfaction, and (c)
change in capacity. Patients respond to these questions firstly by selecting one of four levels of
difficulty: without any difficulty = 0, with some difficulty = 1, require assistance = 2, unable to do =
3. The Total Difficulty Score is expressed as the mean score for the 8 activities. To assess
Satisfaction or dissatisfaction with his or her capacity to perform the selected 8 activities, patients are
asked: "How satisfied are you with your ability to...?" about each of the activities. Response
coding scores were "satisfied" = 0 and "dissatisfied" = 1. To assess Change in Difficulty for the
identical activities, patients are asked about each of the 8 activities: "Compared to 6 months ago,
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how difficult is it NOW (this week) to ...?" Response coding scores were "less difficult now" = 0,
"no change" = 1, and "more difficult now" = 2 (Pincus, et al., 1983).
3.2.1.2 Patient Global Subjective Improvement (GSI)
The GSI is a subjective rating scale aimed at assessing patients' perceived improvement. Patients are
asked to make a general rating of how they perceive their improvement since they have started
treatment by selecting one of 5 alternatives: 1 = deteriorated, 2 = unchanged, 3 = slightly improved,
4 = moderately improved, and 5 = much improved. A higher score indicates greater perceived
improvement (Horven Wigers, et al., 1996).
3.2.1.3 Visual Analog Scale (VAS)
The VAS measures the patient's sensory experience and consists of aIO-cm horizontal line, with 0 =
no symptoms and 10 = worst symptoms as end-descriptors. The VAS has been validated as a
measure for chronic and experimental pain (Scott & Huskisson, 1976; Price, McGrath, Rafii, &
Buckingham, 1983). Five VAS scales were used in the present study. On the day of testing, the
average intensity of the three most central fibromyalgia symptoms, pain, disturbed sleep and fatigue
(lack of energy), were rated on a patient administered VAS, for the past six months. On a fourth
VAS patients had to indicate their perceived global severity. A VAS for physician global assessment
(GAS) was completed by the physician after examination of the patient. Although the physician's
severity ratings clearly do not capture the complex picture of disease available in individual records,
it is the single "objective" measure of health status that is comparable across all patients. Findings
in a study by Bigatti and Cronan (2002) suggest that the easy-to-administer VAS may be the most
useful measure of pain in patients with FMS.
3.2.1.4 Tender Point Score (TPS)
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A TPS system (Simms, et aI., 1991; Nicassio, et aI., 1997) was used in which tenderness was
assessed by the physician by applying pressure maximally to approximately 4 kg/ern- in 9 bilateral
anatomically distinct tender points according to the protocol established by Wolfe, et al. (1990):
occiput, low cervical, mid-point of the trapezius muscle, supraspinatus origin above the scapula spine
near the medial border, second rib at the costochondral junctions, lateral epicondyle, gluteal in upper
outer quadrants of buttocks, greater trochanter and the fatpad of the knee over medial collateral
ligament. The right and left anatomic sites were considered as one since both were equally tender.
The sites were graded as: not tender or mildly tender = 0, moderately tender = 1, and severely tender
= 2. A tender point score (TPS) was computed by adding these graded points, rendering a maximum
score of 18 (Nicassio, et al., 1997; Simms, et al., 1991).
3.2.2 Psychological Variables
The following measuring instruments were used to assess the psychological variables of self-
efficacy, helplessness, social support and cognitive appraisal.
3.2.2.1 Arthritis Self-Efficacy Scale
Self-efficacy was assessed by means of the 20-item Arthritis Self-Efficacy Scale developed by Lorig,
et al. (1989). The scale was designed to measure a patient's beliefs in his or her ability to perform
specific tasks aimed at pain and symptom control and physical functioning. The measure includes 3
subscales: (a) SE for functioning (i.e, performing certain daily activities), (b) SE for pain
management, and (c) SE for controlling other arthritis/fibromyalgia symptoms. A higher score
indicates more self-efficacy. Reasonable standards were met for both construct and concurrent
validity and test-retest reliability. During its development and preliminary testing, a negative high
correlation between an increase in perceived SE and a decline in pain was noted (Lorig, et aI., 1989).
The instrument was also used in numerous studies to assess SE in Fibromyalgia patients (Buckelew,
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et aI., 1998; Burckhardt, et aI., 1994; Franks, et aI., 2004; Mueller, Hartmann, Mueller, & Eich, 2003;
Lynch, 2004), by replacing the word 'arthritis' with 'fibromyalgia'.
3.2.2.2 Helplessness Subscale of the Rheumatology Attitudes Index
The 5-item Helplessness subscale of the Rheumatology Attitudes Index (RAl; DeVellis & Callahan,
1993) was used to assess helplessness beliefs. The Helplessness subscale of the RAl, which is based
on the Arthritis Helplessness Inventory (AHI; Nicassio, Wallston, Callahan, Herbert, & Pincus,
1985), evaluates perceptions of helplessness to control symptoms, including pain (e.g., "I would feel
helpless if I couldn't rely on other people for help with my condition") and disease course ("My
condition is controlling my life"). Higher levels of reported helplessness on the AHI were associated
with higher levels of difficulty, dissatisfaction and pain in carrying out activities of daily living, as
well as the general perception of worsening clinical status (Nicassio, et aI., 1985). The Helplessness
subscale has shown to possess significant internal consistency and correlated stronger with other
measures of clinical outcome than the full length version of the scale (DeVellis & Callahan, 1993).
3.2.2.3 Ouality of Social Support Scale COSSS)
The QSSS, normed on a sample of 194 women with RA, assesses subjects' perceptions of the quality
of social support received from "significant others" in several areas (Goodenow, et aI., 1990). The
17 items of the QSSS, assessed on a 4-point Likert scale, cover the following dimensions: (a)
information and feedback; (b) task assistance; (c) opportunity for confiding; (d) physical affection;
(e) affirmation or ego support and (f) relationship strain (reversed scored). A general index of
perceived quality of social support is obtained by summing across items, with a range of 17 (no
social support) to 68 (complete support in all areas). The study by Goodenow, et al. (1990) showed
higher support levels to be associated with fewer declines in the performance of home and family
activities. Although the study noted several limitations (e.g., the cross-sectional nature of the design;
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the sample of participants in terms of geography and sex), the instrument was used in subsequent
studies for Fibromyalgia patients (Nicassio, et aI., 1997).
3.2.2.4 Pain-Related Self-Statements Scale CPRSS)
The 18-item PRSS (Flor, et aI., 1992) assesses situation-specific cognitions, that may either promote
or hinder patients' attempts to cope with their pain. The PRSS has two scales termed
'Catastrophizing' and 'Coping', which were demonstrated to be valid and sensitive to change. The
scale proved to be valid and reliable for assessment of cognitive patterns relevant to persons suffering
from chronic pain (Flor, et al., 1992; Sarnoch, et al., 1997; Thieme, et al., 2004; ).
3.3 Procedure
All 43 patients were contacted, informed about the study and invited by the researcher to participate.
Written informed consent was obtained. Patients were then individually assessed in a single session
consisting of a medical assessment (about 25 minutes) followed by a psychological assessment
(about 35 minutes). The medical assessments were conducted by the same physician, trained in pain
medicine. This assessment entails completion of a medical assessment form by the physician on the
demographic details of the patient, previous medical history, current medication and symptoms at
onset. This information was used to assess for exlusion criteria. Patients were then questioned about
their perceived pain, fatigue, sleep and global severity, after which they were asked to rate these four
variables on the VAS scales. The physician then gave his rating of the patient on a similar VAS for a
physician global assessment score (GAS). A physical examination was then done for tender point
location and to determine severity, in order to compute a TPS out of 20. Both self-report indices
(VAS; MHAQ) and objective measures (GAS; TPS) of pain severity and functional incapacity were
used to distinguish between subjective and functional aspects of the chronic pain problem.
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During the second half of the session, patients completed the MHAQ, Helplessness Subscale, Self-
Efficacy Scale, QSSS, and PRSS. Each patient was given a booklet consisting of the five different
questionnaires to complete, without any time constraints. The researcher was present at all times to
answer questions where participants needed verification and help.
4. RESULTS
To determine the relationship between functional status (VAS pain, sleep, fatigue, global severity;
physician GAS; TPS; MHAQ and patient GSI) and psychological variables (helplessness, self-
efficacy, quality of social support, and pain-related self-statements), Bravais-Pearson correlations
were used. The results are shown in Table 1 and Table 2.
Table 1
Pearson Correlations between Functional Status Measures and Helplessness, Self-Efficacy CSE)and
Pain-Related Self-Statements (PRSS)
Psychological Variables
Functional Status SE SE SE PRSS PRSS
Measures Helplessness Pain Function Symptom Factorl Factor 2
VAS Pain .39* -.45* -.25 -.13 .36* -.21
VAS Fatigue .10 -.04 -.14 -.11 .34 -.35
VAS Sleep -.07 -.03 -.11 -.23 -.02 -.13
VAS Global Severity .52** -.21 -.31 -.17 .42* -.36*
VASGAS (physician) .49** -.21 -.28 -.18 .52** -.44*
TPS (physician) .27 .06 -.24 -.04 .37* -.30
MHAQ - Difficulty .20 -.32 -.71** -.30 .27 .02
MHAQ - Satisfaction .26 -.24 -.61** -.25 .32 -.29
MHAQ - Change .01 -.02 -.23 -.03 .14 .10
GSI -.30 .38* .39* .13 -.34 .06
VAS = Visual Analogue Scale, GAS = Global Assessment Score, TPS = Tender Point Score,
MHAQ = Modified Health Assessment Questionnaire, GSI = Global Subjective Improvement, SE =
Self Efficacy, PRSS = Pain-Related Self-Statements.
*p< .05, **p< .01.
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Table 1 shows significant positive correlations between Helplessness and VAS Pain (r = .39; Q <
.05), VAS Global Severity Cr = .52; Q < .01), and VAS GAS Cr = .49; Q < .01), indicating that patients
who reported higher levels of helplessness experienced more severe pain, and a higher global
severity of symptoms as rated by themselves (VAS Global Severity) and the physician (VAS GAS).
Significant negative correlations were found between SE Pain and VAS Pain (r = -.45; 12< .05) and
GSI (r = .38; Q < .05), indicating that patients with higher levels of self-efficacy for managing their
pain experienced less physical pain, and also reported that their illness showed improvement after
treatment. Significant negative correlations were found for SE Function and MHAQ-Difficulty (r = -
.71; Q < .01) and MHAQ-Satisfaction (r = -.61; 12< .01), indicating that patients with higher levels of
self-efficacy regarding their functioning experienced activities of daily living as less difficult and
were more satisfied with their ability to execute tasks. SE Function and GSI (r = .39; Q < .05)
showed a positive correlation, indicating that patients with higher levels of self-efficacy regarding
their functioning reported that their illness have improved since receiving treatment. No significant
correlations were found between SE Symptom and any of the functional status measures.
Significant positive correlations were found between PRSS Factor 1 (Catastrophizing) and VAS Pain
(r:::: .36; Q < .05), VAS Global Severity (r= .42; Q < .05), VAS GAS (r = .52; 12< .01) and TPS (r::::
.37; Q < .05). This indicated that patients who reported less pain and global symptom severity
showed less catastrophizing, and the higher the levels of patients' catastrophizing, the higher was the
physician's rating of symptom severity and TPS examination. Significant negative correlations were
found between PRSS Factor 2 (Active Coping), VAS Global Severity (r = .36; 12< .05) and VAS
GAS (r = .44; Q < .05), indicating more active coping abilities by patients that reported and presented
with less global symptom severity.
Stellenbosch University http://scholar.sun.ac.za
18
Table 2
Pearson Correlations between Functional Status Measures and Scores on the Quality of Social
Support Scale (QSSS)
Psychological Variables
Functional Status QSSS QSSS QSSS QSSS QSSS QSSS QSSS
Measures Total Task Relation Ego Physical Info Opportu
VAS Pain .13 .20 -.21 -.03 .10 -.01 .27
VAS Fatigue 040** .35 -.22 .25 .32 .07 .52**
VAS Sleep .04 -.06 .09 -.11 -.03 .23 .06
VAS Global Severity -.05 .03 -.16 -.07 .03 -.07 -.02
VAS GAS (physician) -.05 .03 -.26 -.19 -.05 -.10 .25
TPS (physician) .13 .08 -.15 -.16 .11 .10 .38*
MHAQ - Difficulty -.18 .17 -.52** -047 -.17 .07 -.13
MHAQ - Satisfaction -.29 .02 -.39* -044* -.25 -.07 -.21
MHAQ - Change -.10 -.22 -.11 -040* .03 .23 .11
GSI .22 .08 .26 .21 -.03 .26 .10
VAS = Visual Analogue Scale, GAS = Global Assessment Score, TPS = Tender Point Score,
MHAQ = Modified Health Assessment Questionnaire, GSI = Global Subjective Improvement,
QSSS = Quality of Social Support Scale.
*p< .05, **12<.01.
Table 2 showed a significant positive correlation between QSSS Total and VAS Fatigue (r = 040; 12<
.01), indicating that patients who experienced more support from their family members and friends
reported more fatigue. Significant negative correlations were found between Relationship Strain
(QSSS), and MHAQ-Difficulty (r = -.52; 12< .01) and MHAQ-Satisfaction (r = -.39; 12< .05). Higher
levels of relationship strain between patients and their significant others were thus associated with
less functional difficulty and with feelings of satisfaction with the ability to execute certain tasks.
Significant negative correlations were found between QSSS-subscale of Ego Support or Affirmation,
and MHAQ-Satisfaction (r = -A4; 12< .05) and MHAQ-Change (r = -040; 12< .05). Patients who
perceived more ego support and affirmation from significant others, had less difficulty and was more
satisfied with their ability to perform certain tasks. The significant positive correlations between the
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QSSS-subscale, Opportunity for Confiding, and VAS Fatigue Cr = .52; Q < .01) and TPS Cr = .38; Q <
.05) indicated that patients who had more opportunity to confide in significant others, reported higher
levels of fatigue and had more tender points on the day of examination. No significant correlations
were found between VAS Sleep and any of the psychological measures.
Table 3
Pearson Correlations between the Psychological Variables of Helplessness, Self-Efficacy, Quality of
Social SUPQort and Pain-Related Self-Statements
Psychological Variables
Psychological
Variables 1 2 3 4 5 6 7 8 9 10 11 12 13
1. Helplessness - -A 7** -.38* -.20 -.28 .07 -.35 -.17 -.I 7 -.32 -.32 .72** -.33
2. SE Pain 047** .62** .24 -.02 .35 .19 .21 .12 .26 -.36* .20
3. SE Function AI * .10 -.15 .36* .37* .13 -.07 .04 -.36* .07
4. SE Symptoms .36* .19 .32 .29 040* .12 .15 -.38* .25
5. QSSS Total .75** .14 .75** .76** .57** .62** -.29 .16
6. QSSS Task -.27 .58** .62** .15 .29 -.10 .07
7. QSSS Relation .21 -.00 .17 -.01 -047** .11
8. QSSS Ego .66** .19 .19 -.20 -.09
9. QSSS Physical .16 .32 -.21 .21
10. QSSS Info 045* -.20 .20
Il.QSSS Opportu -.09 .11
12. PRSS Factor1 -046**
13. PRSS Factor2
SE = Self Efficacy, QSSS = Quality of Social Support Scale, PRSS = Pain-Related Self-Statements.
*p< .05, **Q< .01.
Table 3 shows correlations between the psychological measures used in the study. Significant
negative correlations were found between Helplessness and SE Pain Cr = -.47; Q < .01) and SE
Function Cr = -.38; Q < .05), indicating that patients who reported higher levels of helplessness had
less self-efficacy to manage their pain and execute daily activities. A significantly strong positive
correlation was found between Helplessness and PRSS Factor 1 (Catastrophizing) Cr = .72; Q < .01),
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suggesting that patients who reported high levels of helplessness also reported high levels of
catastrophizing.
Strong internal consistency was found with the Self-Efficacy Scale, as significant positive
correlations were shown between all three subscales: SE Pain (r = .47; 12< .01 and r = .62; 12< .01),
SE Function (r = .47; 12< .01 and r = .41; 12< .05), and SE Symptoms (r = .62; 12< .01 and r = .41; 12
< .05). Significant negative correlations were found between all three SE-subscales and PRSS Factor
1 (Catastrophizing): SE Pain (r = -.36; 12< .05), SE Function (r = -.36; 12< .05) and SE Symptoms (r
= -.38; 12< .05), indicating that patients with lower self-efficacy present with higher levels of
catastrophizing. SE Function had significant positive correlations with QSSS Relationship Strain (r
= .36; 12< .05) and QSSS Ego Support (r = .37; 12< .05), and SE Symptoms had significant positive
correlations with QSSS Total (r = .36; 12< .05) and QSSS Physical Affection (r = .40; 12< .05).
Patients' perceived self-efficacy to perform activies of daily living was lower when they experienced
less strain in relationships and received less affirmation. Patients' perceived self-efficacy to manage
other fibromyalgia symptoms was lower when they experienced less support and physical affection
from significant others in their lives.
Except for Relationship Strain, QSSS Total showed strong internal consistency with all its subscales:
Task Assistance (r = .75; 12< .01), Physical Affection Cr = .76; 12< .01), Ego Support (r = .75; 12<
.01), Information and Feedback (r = .57; 12< .01) and Opportunity for Confiding (r = .62; 12< .01).
The Relationship Strain subscale had a significant negative correlation with PRSS Factor 1
(Catastrophizing) (r = -.47; 12< .01), indicating less catastrophizing tendencies in patients who
experienced more strain in their relationships. A significant negative correlation between PRSS
Factor 1 (Catastrophizing) and PRSS Factor 2 (Active Coping) (r = -.46; 12< .01) indicated that
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patients who engaged with active coping styles also had less tendency to catastrophize about their
illness.
Table 4
Pearson Correlations between the Functional Status Measures: VAS Pain, VAS Fatigue, VAS Sleep,
VAS Global Severity, VAS GAS, TPS, MHAQ - Difficulty, MHAQ - Satisfaction, MHAQ -
Change, and GSI
Functional Functional Status Measures
Status
Measures 1 2 3 4 5 6 7 8 9 10
1. VAS Pain .63** -.20 .54** .70** ,48** .26 .24 .28 -,49**
2. VAS Fatigue .08 .50** .67** .55** .18 .24 .06 -.13
3. VAS Sleep .27 .21 .23 .08 .21 .13 .31
4. VAS Global .77 .62** .20 .29 .06 -.06
5. VAS GAS .78** .32 ,45* .26 -.25
6. TPS .17 .27 .37 -.04
7. MHAQ (Difficulty) .81** .36* -,42*
8. MHAQ (Satisfaction) .50** -.38*
9. MHAQ (Change) -,41 *
10. GSI
VAS = Visual Analogue Scale, GAS = Global Assessment Score, TPS = Tender Point Score,
MHAQ = Modified Health Assessment Questionnaire, GSI = Global Subjective Improvement.
*.Q< .05, **.Q< .01.
The VAS Pain measure showed significant positive correlations with VAS Fatigue (r = .63; .Q< .01),
VAS Global Severity (r = .54; .Q < .01), VAS GAS Cr = .70; .Q < .01) and TPS Cr = .48; .Q < .01),
indicating that patients with higher pain levels also experienced more fatigue, a higher global severity
of symptoms, poor global functioning as assessed by the physician, and more tender points on
examination. VAS Pain had a significant negative correlation with GSI Cr = -.49;.Q < .01), indicating
more improvement reported by patients who experienced less pain. Significantly strong positive
correlations were found between VAS Fatigue and VAS Global Severity (r = .50; .Q < .01), VAS
GAS (r = .67; .Q < .01), and TPS (r = .55; .Q < .01). Thus, patients with higher fatigue levels
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experienced more global severity of their illness, a poor physician's rating concerning their global
functioning and a higher tender point score. Significant positive correlations were found between
TPS, VAS Global (r = .62; Q < .01), and VAS GAS (r = .78; Q < .01), showing the level of subjective
and objective global severity to increase with the number of tender points. No significant
correlations were found on the VAS Sleep measure.
Strong internal consistency was found for the MHAQ, as all three subscales correlated significantly
with each other. GSI had significant negative correlations with all three MHAQ subscales
(Difficulty, Satisfaction and Change), indicating less functional difficulty, more satisfaction and
more change to be associated with subjective improvement after treatment. The MHAQ Satisfaction
subscale had a significant positive correlation with VAS GAS (r = .45; Q < .05), indicating a poor
rating on patient functioning by the physician when a patient was dissatisfied with his or her ability
to do certain tasks.
5. DISCUSSION
It was initially planned to divide the patients into responders and nonresponders to treatment, and to
compare these two groups in terms of the psychological variables. For this purpose the preliminary
response criteria developed by Simms, et al. (1991) were used. These criteria successfully
distinguished between treated and placebo patients, and identified those patients who underwent
substantial improvement when conventional outcome measures were used. Thus, on the basis of
patients' TPS, VAS for sleep and VAS physician global assessment score, only four responders and
six nonresponders out of the total group of 31 patients were identified. Comparison of these two
subgroups in terms of psychological variables was not possible, due to the small sizes of the
subgroups. However, this result is similar to results from other FMS studies, showing that the low
percentage of explained variance may be due to the heterogeneity of fibromyalgia. Additionally, the
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small number of responders may suggests that current forms of treatment are not effective for a large
portion of the fibromyalgia population (Giesecke, et aI., 2003; King, Wessel, Bhambhani, Sholter, &
Maksymowych, 2002; Thieme, et aI., 2004). Consequently, a correlational approach was used.
Results of the present study indicated significant correlations between patient-administered measures
(VAS Pain, Fatigue and Global Severity) and physician's ratings (VAS GAS and TPS), offering
support for the VAS as a measure of functional status. The global rating of severity by the patients
(VAS Global Severity) and the physician (VAS GAS) correlated positively, as well as with measures
of helplessness, catastrophizing and active coping. This indicates that the patient's global severity, as
rated by themselves and the physician, was probably mediated by the patient's level of
catastrophizing, helplessness and active coping. These findings are in accordance with the results
reported by Martin, et al. (1996) that maladaptive coping efforts predict an objective impression and
subjective experience of disability in patients with primary fibromyalgia. Cognitive appraisals, such
as catastrophizing, active or passive coping, and vigilance to pain have a more pronounced role in the
self-reported pain of patients with FMS than in patients with RA and chronic low back pain
(Crombez, Eccleston, Van Den Broeck, Goubert, & Van Houdenhove, 2004; Hassett, Cone, Patella,
& Sigal, 2000). The VAS Sleep measure showed no correlation with any functional status or
psychological measures. The use of low dose tricyclic antidepressants used by more than half the
sample may account for this result.
Contrary to what was expected, self-reported VAS Fatigue increased with the total amount of
perceived social support as well as the opportunity available for confiding in family or friends.
Similarly, patients perceived more relationship strain when they showed lower levels of
catastrophizing, higher levels of self-efficacy to function, and less difficulty and more satisfaction in
managing their daily activities. The presence of relationship strain did not predict greater reports of
Stellenbosch University http://scholar.sun.ac.za
24
pain, lower self-efficacy and perceived unimprovement as found by Turk, Kerns, & Rosenberg
(1992), and neither was more support from others associated with less fatigue in patients. A possible
explanation may be found in the overt pain behaviours displayed by patients. Pain behaviours (i.e.
overt expressions of pain) are observable and have the potential to elicit responses from others.
These responses of significant others may serve as reinforcers of pain behaviours and may lead to
increased expression of the initial behaviours even in the absence of physical symptomatology. The
important role of reinforcement on the maintenance of pain behaviours has been reported in several
studies (Romano, et al., 1995; Turk & Ellis, 2003; Turk, Kerns, & Rosenberg, 1992). Patients are
not intentionally being manipulative, but through conditioning, anticipated consequences may come
to control their behaviour. Family members who react with undesired responses such as skepticism
or criticism to a patient's fatigue and pain behaviours may condition a patient to deny or minimize
his or her true experience of pain and fatigue. The patient may then ignore his or her symptoms and
may overdo activities, experiencing increased symptomatology, as well as conflict,withdrawal, or
other additional distress (Turk & Ellis, 2003).
The strong positive correlation between helplessness and the cognitive appraisal of catastrophizing
may be indicative of a possible mediating relationship between these two variables. Little, if any
studies have been published where both constructs were examined. Path analytic procedures
revealed that helplessness fully mediated the effects of pain on self-reported pain behaviour
(Nicassio, et al., 1999). Further studies on catastrophizing in FMS might aid with an understanding
of its mediational capacities, if any, and its relationship to helplessness. Two points of departure
may be considered: (a) the uncertainty regarding the cause, treatment and outcome of FMS may
contribute to considerable subjective anxiety, passive resignation and other forms of dysfunctional
coping behaviour (e.g. helplessness; catastrophizing) in FMS patients, and (b) feelings of isolation
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experienced by patients due to significant others' and/or clinicians' lack of understanding of their
difficulties to cope with FMS may result in extreme overt expression of pain and other dysfunctional
behaviours (e.g. helplessness and catastrophizing).
The negative association between all three subscales of the Arthritis Self-Efficacy Scale and PRSS
Catastrophizing-subscale could be partially explained by findings on chronic fatigue syndrome
(CFS). Findley, Kerns, Weinberg and Rosenberg (1998) concluded that increased coping ability may
mediate, or be mediated by, improved self-efficacy expectations, which has also been shown to be a
moderator, for example, of CFS symptoms. In the present study, self-efficacy tended to increase
when patients displayed less catastrophizing. Increased pain behaviours have been associated with
higher levels of depression, greater satisfaction with social support, reduced self-efficacy for control
of pain, and more negative thoughts (Keefe, Wilkins, Cook, Crisson, & Muhlbaier, 1986).
There are a number of limitations that may have influenced the results of the present study. It was
conducted with patients being regularly seen at a medical center, and thus who may have more severe
symptoms. In addition, the median duration of disease was 4.90 years, indicating that the patients
had an established rather than early disease. As no control group was used, it cannot be concluded
that these results are specific to FMS.
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